-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $48

Benzinga·10/13/2026 16:25:02
Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $50 to $48.